COMMUNIQUÉS West-GlobeNewswire

Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
31/07/2026
Randomized Phase 2a PRECISION-E2 study designed to evaluate a predefined panel of genes to advance personalized medicine in women's health PHILADELPHIA, July 31, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: [...]
Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results
31/07/2026
Staking revenue of $2.2 million for the quarter and $4.7 million for the first half of 2026 SDEV grew its SKY position to 2.29 billion tokens (approximately 10% of total SKY supply) and eliminated all remaining warrant [...]
Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026
31/07/2026
–First public scientific presentation provides the biomedical engineering community with its first detailed view of the next-generation total artificial heart platform– TUCSON, Ariz., July 31, 2026 (GLOBE NEWSWIRE) -- [...]
Ally Medical Emergency Room's Record-Breaking Pet Supply Donation Drive Returns Bigger Than Ever This August
31/07/2026
Following last year's record 6,000+ items collected, Texans across Austin, Dallas-Fort Worth and Houston areas can donate pet supplies at any Ally Medical ER location Aug. 1-31 to benefit Austin Pets Alive!, Dallas Pets [...]
Rose Hill Life Sciences and Control Z Sign Letter of Intent to Advance Clinically Structured Psilocybin-Assisted Therapy for PTSD
31/07/2026
Partnership establishes the framework for the first regulated psychedelic therapy program in the Commonwealth, uniting Rose Hill’s pharmaceutical-grade Psychedelic Therapeutic Intervention (PTI)™ protocol with Control Z [...]
BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
31/07/2026
LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex [...]
Vireo Growth Inc. Announces a Four-Deal Transaction to Establish Presence in Ohio
31/07/2026
Further Expands Vireo's National Platform, Creating One of the Industry's Broadest State Footprints MINNEAPOLIS, July 31, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company [...]
Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy
31/07/2026
MILAN, Italy, July 31, 2026 – Italfarmaco S.p.A. today announced a managed entry agreement with the Georgian Ministry of Health for givinostat (Duvyzat ® ) as a treatment for patients with Duchenne muscular dystrophy ( [...]
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026
30/07/2026
SARATOGA, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced [...]
Annexon Secures Strategic Credit Facility for up to $200 Million from Oxford Finance
30/07/2026
Expands Financial Capacity as Vonaprument and Tanruprubart Programs Advance Toward Registration BRISBANE, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the [...]
Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics
30/07/2026
Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 members Raises the midpoint of all full-year guidance [...]
SlimTide Official Website 2026: Launch Effective Weight Loss Formula for Healthy Digestion and Metabolism. Slim Tide capsules Highlights Ingredients, Supplement Facts.
30/07/2026
SlimTide introduces natural weight loss capsules formulated to support healthy digestion and metabolism with plant-based ingredients. Learn about the formula, key ingredients, daily use, manufacturing information, [...]
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod
30/07/2026
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod La Société confirme être en bonne voie pour déposer, d’ici la fin de l’année 2026, sa première demande d’autorisation [...]
Mdxhealth to Release Second Quarter 2026 Financial Results on August 13
30/07/2026
Company to Host Conference Call with Live Q&A, August 13, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – July 30, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, [...]
InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing
30/07/2026
Ms. Kennedy returns to InspireMD having previously served as Sales Director supporting the initial U.S. launch of CGuard Prime MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the [...]
Correction: Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
30/07/2026
Trésorerie et équivalents de trésorerie de 166,1 millions d'euros et 67,8 millions d'euros de dépôts à court terme 2 au 30 juin 2026 Daix (France), New York City (New York, États-Unis), le 30 juillet, 2026 – Mise à jour [...]
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
30/07/2026
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod Company remains on track to submit its first New Drug Application for obefazimod for the treatment of moderately to severely active ulcerative [...]
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
30/07/2026
BOSTON, July 30, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced it [...]
Correction: Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
30/07/2026
Cash and cash equivalents at €166.1 million and €67.8 million in short-term deposits 2 as at June 30, 2026 Daix (France), New York City (New York, United States), July 30, 2026 – Update to Press Release Dated July 29, [...]

Pages